Knowledge, Attitudes and Practices Towards Human Papillomavirus Vaccination Among Medical Doctors at a Tertiary Hospital: A Cross Sectional Study

Abstract

Background Human papillomavirus (HPV) infection is a common sexually transmitted disease, characterised by persistent infection with high-risk strains leading to malignant conditions such as cervical cancer. The HPV vaccine is a well-known primary preventive measure for HPV infections. Previous studies have shown that medical doctors’ vaccine recommendation is one of the key strategies in improving HPV vaccine uptake. In 2019, Zambia rolled out the free national HPV vaccination program targeting 14-year-old girls. However, the annual coverage for HPV vaccination is variable, with rates as low as 33% for 2021. Materials and Methods We conducted a cross-sectional study between September and December 2020 at the University Teaching Hospitals in Lusaka, Zambia. We used analysis of variance to assess the mean differences in the overall scores for knowledge, attitude and practices towards the HPV vaccine. In addition, we used structural equation modelling (SEM) to test the traditional education theory as medical doctors’ HPV vaccine knowledge, attitude, and practices cover several facets, and SEM can model latent variables. Results We enrolled 121 medical doctors, of whom 67 (44.6%) were male. The majority, 76 (62.8%), were registrars and 79 (65.3%) had more than ten years of clinical experience. The overall mean knowledge, attitude, and practice score of the HPV vaccine mean (SD) were 70.2 (15.1), 72.1 (18.5) and 77.1 (28.9), respectively. More than half of the medical doctors would advise anyone eligible to take the HPV vaccine 66 (54.6%). There was a positive correlation between attitude and practice towards the HPV vaccine (β = .03, P = .017). Conversely, there was no evidence of a correlation between overall HPV knowledge and attitude (β = .01, P = .670) and rank of the medical doctors (β = −7.87, P = .355). Conclusion Knowledge was high with good attitudes and practices among medical doctors, which are vital in vaccine recommendation and subsequent uptake.

Stakeholders’ perspectives on barriers to and facilitators of school-based HPV vaccination in the context of COVID-19 pandemic-related disruption: a qualitative mixed methods study

“…Our study corroborated the factors on HPVV uptake we had previously summarized in our review from across English Canada (Khan et al, 2023 ) in the context of SK. The study findings align with the literature that HPVV uptake is largely hindered by vaccine attitudes driven by either lack of awareness (Cartmell et al, 2018 ) information and literacy (Alhusayn et al, 2022 ; Fernandes et al, 2018 ) or its adequacy (Lubeya et al, 2022 ). The study adds to the literature by highlighting the context-specific barriers and facilitators to the uptake of HPVV at three different levels across SK in an attempt to provide views from multiple prescriptive.…”

Knowledge and Attitudes towards Human Papillomavirus Vaccination (HPV) among Healthcare Providers Involved in the Governmental Free HPV Vaccination Program in Shenzhen, Southern China

“…Healthcare provider (HCPs) recommendations are a significant factor that motivates the general population and parents to vaccinate their children against HPV [ 16 , 17 , 18 , 19 ]. Additionally, knowledge of HPV-related issues is a crucial predictor of HCP confidence and a willingness to recommend HPV vaccines [ 20 , 21 , 22 ]. Previous studies have also identified various factors that impact HCPs’ knowledge of HPV and HPV vaccines, including their profession, type of license, age, education level, and job title [ 23 , 24 ].…”

Actions speak louder than words; pediatricians, gynecologists, nurses, and other mothers’ perspectives on the human papillomavirus vaccine: an Istanbul multicenter study

“…Sixty-nine (65.3%) of the physicians in their survey study had more than 10 years of clinical experience. A total of 66 (54.6%) physicians recommended HPV vaccination ( 5 ). On the contrary, physicians were more likely to recommend the vaccine in our study.…”